Ballsy Celgene Continues to Tread Carefully Into Neurosciences Post author:Sam Post published:January 25, 2018 Post category:BioPharma The company made some bold moves this month in acquiring Juno and Impact Source: BioSpace You Might Also Like Oxford BioMedica Wins $105M Gene Therapy Contract From Bioverativ February 14, 2018 Serial Biotech Entrepreneur to Helm Biotech Startup After Retiring From Harvard February 22, 2017 Besties Regeneron, Sanofi Show Off Phase II Skin Cancer Data December 12, 2017
